Ex vivo addition of anti-PD-L1 blocking antibody caused increased T cell proliferation and IFNγ production, indicating that in some patients with deregulated PD-1/PD-L1 expression, checkpoint inhibition might reinstate the GVL effect against relapsed AML (34). This evidence concerns the gene PDCD1 and acute myeloid leukemia.